Cargando…
The retrospective and observational study of catatonia – Diagnosis, course of illness, and the response to lorazepam – in a tertiary health-care center
OBJECTIVES: In patients with catatonia, it has been discovered that benzodiazepines (BZD) have a remarkable impact. However, there is not much evidence reflecting the long-term treatment with only BZDs before considering electroconvulsive therapy. MATERIALS AND METHODS: One-year retrospective data o...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174141/ https://www.ncbi.nlm.nih.gov/pubmed/37181172 http://dx.doi.org/10.25259/JNRP_36_2022 |
_version_ | 1785039971040624640 |
---|---|
author | Latke, Rahul Sinha, Deoraj Miskin, Tejaswini Mane, Astik |
author_facet | Latke, Rahul Sinha, Deoraj Miskin, Tejaswini Mane, Astik |
author_sort | Latke, Rahul |
collection | PubMed |
description | OBJECTIVES: In patients with catatonia, it has been discovered that benzodiazepines (BZD) have a remarkable impact. However, there is not much evidence reflecting the long-term treatment with only BZDs before considering electroconvulsive therapy. MATERIALS AND METHODS: One-year retrospective data of patients obtained from the health management information system (HMIS) portal and records of the department of psychiatry with the diagnosis of catatonia. This data was then analyzed for adequate history, presenting complaints, treatment taken, substance use, and was organized into five groups depending on the primary diagnosis as per the Diagnostic and Statistical Manual of Mental. The scores of Bush-Francis Catatonia Rating Scales of day 1 and subsequent follow-ups were secured. Categorical variables were analyzed with the Chi-squared test. The response overtime for all the groups and its correlation with the number of visits was compared using repeated measures analysis of variance. RESULTS: We found that the lorazepam challenge test versus improvement after 1 week of oral lorazepam had Pearson’s correlation of 0.604, this correlation decreased in the following weeks. In the 3 week, the correlation was 0.373, which was statistically significant. This shows that the highest correlation was seen in the 1(st) week. Hence, our study suggested that lorazepam challenge test is a good predictor of response in the 1(st) week alone. We observe negative correlation which is significant in the 3(rd) week (P = 0.048) and not in the 1(st) and 2(nd) week. CONCLUSION: Our study analyzed the patients with catatonia in psychiatric diagnostic categories, history, and the outcome after treating them with lorazepam at every visit over 3 weeks. The correlation in the level of improvement of symptoms at subsequent visits was noteworthy and had a strong association with the lorazepam challenge test. When dose of lorazepam was tapered, on an average dose was reduced in the 2(nd) week. Suggesting that at least 3 week treatment would be ideal. |
format | Online Article Text |
id | pubmed-10174141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Scientific Scholar |
record_format | MEDLINE/PubMed |
spelling | pubmed-101741412023-05-12 The retrospective and observational study of catatonia – Diagnosis, course of illness, and the response to lorazepam – in a tertiary health-care center Latke, Rahul Sinha, Deoraj Miskin, Tejaswini Mane, Astik J Neurosci Rural Pract Original Article OBJECTIVES: In patients with catatonia, it has been discovered that benzodiazepines (BZD) have a remarkable impact. However, there is not much evidence reflecting the long-term treatment with only BZDs before considering electroconvulsive therapy. MATERIALS AND METHODS: One-year retrospective data of patients obtained from the health management information system (HMIS) portal and records of the department of psychiatry with the diagnosis of catatonia. This data was then analyzed for adequate history, presenting complaints, treatment taken, substance use, and was organized into five groups depending on the primary diagnosis as per the Diagnostic and Statistical Manual of Mental. The scores of Bush-Francis Catatonia Rating Scales of day 1 and subsequent follow-ups were secured. Categorical variables were analyzed with the Chi-squared test. The response overtime for all the groups and its correlation with the number of visits was compared using repeated measures analysis of variance. RESULTS: We found that the lorazepam challenge test versus improvement after 1 week of oral lorazepam had Pearson’s correlation of 0.604, this correlation decreased in the following weeks. In the 3 week, the correlation was 0.373, which was statistically significant. This shows that the highest correlation was seen in the 1(st) week. Hence, our study suggested that lorazepam challenge test is a good predictor of response in the 1(st) week alone. We observe negative correlation which is significant in the 3(rd) week (P = 0.048) and not in the 1(st) and 2(nd) week. CONCLUSION: Our study analyzed the patients with catatonia in psychiatric diagnostic categories, history, and the outcome after treating them with lorazepam at every visit over 3 weeks. The correlation in the level of improvement of symptoms at subsequent visits was noteworthy and had a strong association with the lorazepam challenge test. When dose of lorazepam was tapered, on an average dose was reduced in the 2(nd) week. Suggesting that at least 3 week treatment would be ideal. Scientific Scholar 2023-05-03 2023 /pmc/articles/PMC10174141/ /pubmed/37181172 http://dx.doi.org/10.25259/JNRP_36_2022 Text en © 2023 Published by Scientific Scholar on behalf of Journal of Neurosciences in Rural Practice https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Latke, Rahul Sinha, Deoraj Miskin, Tejaswini Mane, Astik The retrospective and observational study of catatonia – Diagnosis, course of illness, and the response to lorazepam – in a tertiary health-care center |
title | The retrospective and observational study of catatonia – Diagnosis, course of illness, and the response to lorazepam – in a tertiary health-care center |
title_full | The retrospective and observational study of catatonia – Diagnosis, course of illness, and the response to lorazepam – in a tertiary health-care center |
title_fullStr | The retrospective and observational study of catatonia – Diagnosis, course of illness, and the response to lorazepam – in a tertiary health-care center |
title_full_unstemmed | The retrospective and observational study of catatonia – Diagnosis, course of illness, and the response to lorazepam – in a tertiary health-care center |
title_short | The retrospective and observational study of catatonia – Diagnosis, course of illness, and the response to lorazepam – in a tertiary health-care center |
title_sort | retrospective and observational study of catatonia – diagnosis, course of illness, and the response to lorazepam – in a tertiary health-care center |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174141/ https://www.ncbi.nlm.nih.gov/pubmed/37181172 http://dx.doi.org/10.25259/JNRP_36_2022 |
work_keys_str_mv | AT latkerahul theretrospectiveandobservationalstudyofcatatoniadiagnosiscourseofillnessandtheresponsetolorazepaminatertiaryhealthcarecenter AT sinhadeoraj theretrospectiveandobservationalstudyofcatatoniadiagnosiscourseofillnessandtheresponsetolorazepaminatertiaryhealthcarecenter AT miskintejaswini theretrospectiveandobservationalstudyofcatatoniadiagnosiscourseofillnessandtheresponsetolorazepaminatertiaryhealthcarecenter AT maneastik theretrospectiveandobservationalstudyofcatatoniadiagnosiscourseofillnessandtheresponsetolorazepaminatertiaryhealthcarecenter AT latkerahul retrospectiveandobservationalstudyofcatatoniadiagnosiscourseofillnessandtheresponsetolorazepaminatertiaryhealthcarecenter AT sinhadeoraj retrospectiveandobservationalstudyofcatatoniadiagnosiscourseofillnessandtheresponsetolorazepaminatertiaryhealthcarecenter AT miskintejaswini retrospectiveandobservationalstudyofcatatoniadiagnosiscourseofillnessandtheresponsetolorazepaminatertiaryhealthcarecenter AT maneastik retrospectiveandobservationalstudyofcatatoniadiagnosiscourseofillnessandtheresponsetolorazepaminatertiaryhealthcarecenter |